Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Incyte Corp (NQ: INCY)
66.06 USD  +1.62 (+2.51%)
Official Closing Price  /  Updated: 7:16 PM EDT, Oct 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,635,900
Open 64.49
Bid (Size) 63.51 (1)
Ask (Size) 66.06 (1)
Prev. Close 64.44
Today's Range 63.75 - 67.02
52wk Range 60.23 - 117.95
Shares Outstanding 211,969,163
Dividend Yield N/A
Performance
YTD
-34.52%
-34.52%
1 Month
-1.77%
-1.77%
3 Month
-4.54%
-4.54%
6 Month
-3.46%
-3.46%
1 Year
-42.19%
-42.19%
Featured News
More News
You may be surprised at how many S&P 500 stocks have fallen at least 50% from record highs
Still, analysts have favorable views on some of them. Read More
category BEN , Industrial Products & Services , WYNN , and 54 more.
from MarketWatch
As S&P 500 rises to a record, these laggards are expected to come roaring back
Analysts see double-digit upside for many of this year’s worst-performing large-cap stocks. Read More
category Food and Beverage , NLSN , Biotechnology , and 55 more.
from MarketWatch
Featured News
Read More
U.S. companies’ sales growth is accelerating — here are the biggest winners
category Economy , HFC , PYPL , and 60 more.
from MarketWatch
This stock sector most often beats analysts’ estimates
category Health/Care , Earnings/Earnings Advisories , GILD , and 27 more.
from MarketWatch
Here are Friday’s worst stocks as trade conflict and a weak jobs report disappoint investors
category PYPL , Aerospace , GE , and 65 more.
from MarketWatch
As stocks recover, Goldman sees ‘lowered bar’ for volatility’s return
category Medical Products , MYL , DJIA , and 11 more.
from MarketWatch
In the bull market’s ninth year, ‘winning’ stocks hide lingering pain
category ULTA , STX , HBAN , and 73 more.
from MarketWatch
Five biotech buyout candidates you should look at right now
category Opinion , BMRN , XBI , and 15 more.
from MarketWatch
More News
Read More
Report: Developing Opportunities within Packaging Corporation of America, Jones Energy, Pitney Bowes, Mercury General, Invacare, and Incyte — Future Expectations, Projections Moving into 2018
from GlobeNewswire News Releases
Amid Broader Downturn, These 3 Biotech Stocks Look 'Compelling'
from Investor's Business Daily
Phase 2 GEOMETRY mono-1 Trial of Investigational Medicine Capmatinib Shows Positive Results in Patients with MET-mutated Advanced NSCLC
from Business Wire News Releases
Incyte to Report Third Quarter Financial Results
from Business Wire News Releases
Incyte Announces Data for Pemigatinib, its Selective FGFR Inhibitor, to be Featured at the ESMO 2018 Congress
from Business Wire News Releases
These Biotechs Are Poised As 'Standouts' Heading Into Earnings
from Investor's Business Daily
Stock News Today: Tech Stocks Strengthen After Fed Rate Hike
from Investor's Business Daily
Incyte Becomes #24 Most Shorted Nasdaq 100 Component, Replacing Hologic
category Stocks
from Market News Video
In Honor of MPN Awareness Day and Blood Cancer Awareness Month, Incyte Debuts Documentary Spotlighting Myeloproliferative Neoplasms (MPNs)
from Business Wire News Releases
Incyte Announces Positive Data from Phase 2b Trial of Ruxolitinib Cream in Patients with Atopic Dermatitis
from Business Wire News Releases
First Week of October 19th Options Trading For Incyte Corporation
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

WHAT'S POPULAR IN THE VILLE